Oral pharmaceutical solutions containing telbivudine

Details for Australian Patent Application No. 2008274170 (hide)

Owner Novartis AG

Inventors Sekkat, Nabila

Agent Davies Collison Cave

Pub. Number AU-B-2008274170

PCT Pub. Number WO2009/007426

Priority 07112381.4 12.07.07 EP

Filing date 10 July 2008

Wipo publication date 15 January 2009

Acceptance publication date 9 June 2011

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2009/007426 Priority application(s): WO2009/007426

9 June 2011 Application Accepted

  Published as AU-B-2008274170

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008274171-Novel antibodies inhibiting c-Met dimerization, and uses thereof

2008274161-Novel esterases and their use